12 April 2018

13 Apr 2018

Innovation in Design and Acquisition for Compound Screening Libraries

Medicinal chemists, synthetic chemists, computational chemists and compound management teams from industry and academia all know: a screen is only as good as the molecules that go into it.

With the vast potential of chemical space, how do you decide what to include in your virtual, high-throughput, or fragment-based screen?

This one-day symposium on Tuesday 15 May 2018, organised by SCI's Fine Chemicals group and the Academic Drug Discovery Consortium (ADDC), seeks to inform and create a dynamic environment for discussion around this important topic. In this ever-evolving area, it is critical to understand the current design and selection methods of compound screening libraries, along with the range of available business models for library acquisition and enhancement.

The conference will be especially useful to chemists involved in library design and acquisition - along with those involved in hit and lead generation, primarily in drug discovery and agrochemistry.

Presentations from industry, academia and commercial compound vendors will cover computational design, focused library sets for phenotypic screening, 3D fragment libraries, attention to physicochemical properties on current library design methodology, opportunities from advances in synthetic organic chemistry, and the compound acquisition market place. There will be ample opportunities for discussion and networking while browsing stands from the leading suppliers.

Poster submissions are encouraged. Relevant topics include chemical methodology for library synthesis, design of innovative chemical libraries using computational and experimental approaches, and case studies demonstrating the value of a designed library.

Confirmed speakers include;

Heather Tye

Dr Heather Tye CChem, FRSC
VP Medicinal Chemistry
Evotec UK

John Irwin

John Irwin
Associate Professor
UCSF Pharmaceutical Chemistry

Yun Ding

Yun Ding
Scientific Leader
GlaxoSmithKline R&D

Dietmar Wolf

Dietmar Wolf, PhD
Executive Vice President
AnalytiCon Discovery

Dean Brown

Dean Brown
Director of External Chemistry
AstraZeneca Pharmaceuticals

This event is sponsored by the ADDC

Related Links

Show me news from
All themes
All categories
All years
search by